The JDRF CRN Symposium 2023 Presentations
The JDRF CRN Symposium recently took place in Sydney, bringing together a multidisciplinary network of scientific and non-scientific experts to showcase the lifechanging research that CRN-funding has made possible over the past decade, as well as the funding’s impact on the T1D research environment and T1D research ecosystem.
If you were unable to attend or would like to revisit some of the Presentations, please click the applicable heading to view the recording.
For further information kindly contact Kellie Millard.
Download a comprehensive summary of the CRN symposium here.
Day One Presentations
Welcome and Opening – JDRF CRN SYMPOSIUM T1Decade of Research Progress – Past & Future
• Mr Mike Wilson OAM, Chief Executive Officer JDRF Australia – Acknowledgement of country and welcome
• The Hon Mark Butler, Minister for Health and Aged Care – Opening address
• Young type 1 diabetes (T1D) research advocates
• Dr. Dorota Pawlak, Chief Scientific Officer JDRF Australia – Overview of the Type 1 Diabetes Clinical Research Network
• Prof. Mark Atkinson, Director, University of Florida Diabetes Institute – Introduction to the JDRF Clinical Research Network Symposium
Keynote speakers – Early Diagnosis
• Patient voice
• Prof Jennifer Couper – The first 1000 Days
• Prof Marian Rewers – Paradigm shifts in prevention and treatment of T1D
Rapid Fire – Early Diagnosis
• Prof John Wentworth – An overview of the Type1Screen program since its inception in 2019
• Dr Kirstine Bell – Paving the way towards a national screening program for type 1 diabetes all Australian children
• A/Prof Emma Hamilton-Williams – Targeting the gut microbiota to prevent type 1 diabetes
• Dr Ki Wook Kim – Antiviral vaccines for primary prevention of type 1 diabetes
Panel Discussion – Primary Prevention
EXPERT PANEL:
Prof Marian Rewers, Prof Jennifer Couper, Prof Edwin Kirk AO, A/Prof John Wentworth, Prof Maria Craig, Prof William Rawlinson, Ms Melanie Cullen, Ms Renza Scibilia, Dr Gina Agiostratidou
Morning Recap Day One
Highlights, learnings, barriers and where to next in early diagnosis and prevention
Presenter: A/Prof Emma Hamilton-Williams
Keynote speakers – Intercepting and Delaying
• Patient voice
• Prof Colin Dayan – Moving towards insulin-free T1D….what is stopping us?
• Prof Thomas Kay – The BANDIT trial – where to next?
• Dr Leni (Eleanor) Ramos – Disease modifying therapies – Teplizumab
Hot Topic – Disease Modifying Therapies
• Prof Ranjeny Thomas AM – New therapies/learnings from other autoimmune diseases
• Dr Irina Buckle – RAGE targeted therapies for T1D prevention
• Prof Helen Thomas – JAK inhibitors/ target validation/BANDIT
• Dr Andrew Sutherland – Contemporary immunology of T1D: exploring new frontiers and opportunities
Panel Discussion – Opportunities and Barriers
EXPERT PANEL
Prof Tom Kay, Prof Colin Dayan, Prof Ranjeny Thomas AM, Prof Kim Donaghue, Prof Simon Barry, Prof Fabienne Mackay, Ms Christine Garberg, Dr Elanor Ramos, Dr Sanjoy Dutta, Dr Katja Beitat
Afternoon Recap Day One
Highlights, learnings, barriers and new directions in intercepting and delaying the course of T1D development.
Presenter: A/Prof Tony Hunyh